[VYNE] QoQ Quarter Result on 30-Jun-2017 [#Q2]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
29-Jun-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -12.40%
YoY-
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 10,143 497 2,775 909 449 449 450 702.50%
PBT -8,347 -12,657 -9,277 -8,172 -6,153 -5,474 -4,837 44.01%
Tax 0 0 -2 0 0 0 0 -
NP -8,347 -12,657 -9,277 -8,172 -6,153 -5,474 -4,837 44.01%
Tax Rate - - - - - - - -
Total Cost 18,490 13,154 12,052 9,081 6,602 5,923 5,287 130.93%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -82.29 -2,546.68 -334.31 -899.01 -1,370.38 -1,219.15 -1,074.89 -82.05%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -26.28 -51.83 -32.43 -50.99 -38.39 -34.16 -30.18 -8.83%
EPS Diluted -26.28 -51.83 -32.43 -50.99 -38.39 -34.16 -30.18 -8.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.